The estimated Net Worth of David William Bespalko is at least $5.28 millier dollars as of 15 March 2022. David Bespalko owns over 11,469 units of Chembio Diagnostics stock worth over $5,276 and over the last 4 years David sold CEMI stock worth over $0.
David has made over 1 trades of the Chembio Diagnostics stock since 2022, according to the Form 4 filled with the SEC. Most recently David exercised 11,469 units of CEMI stock worth $5,276 on 15 March 2022.
The largest trade David's ever made was exercising 11,469 units of Chembio Diagnostics stock on 15 March 2022 worth over $5,276. On average, David trades about 3,823 units every 0 days since 2021. As of 15 March 2022 David still owns at least 11,469 units of Chembio Diagnostics stock.
You can see the complete history of David Bespalko stock trades at the bottom of the page.
David's mailing address filed with the SEC is C/O CHEMBIO DIAGNOSTICS, INC., 3661 HORSEBLOCK ROAD, MEDFORD, NY, 11763.
Over the last 20 years, insiders at Chembio Diagnostics have traded over $909,824 worth of Chembio Diagnostics stock and bought 3,754,893 units worth $1,696,058 . The most active insiders traders include Credit Advisors, Llcpercept..., Lawrence A. Siebert et Richard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of $36,203. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth $109,552.
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.
Chembio Diagnostics executives and other stock owners filed with the SEC include: